June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Accelerate Epi-on versus standard epi-off corneal crosslinking for progressive keratoconus in pediatric patients.
Author Affiliations & Notes
  • Luis Izquierdo
    Ophthalmology, Instituto Oftalmo Salud, Lima, Peru
  • Maria A Henriquez
    Ophthalmology, Instituto Oftalmo Salud, Lima, Peru
  • ana rodriguez
    Ophthalmology, Instituto Oftalmo Salud, Lima, Peru
  • giovanna henriquez
    Ophthalmology, Instituto Oftalmo Salud, Lima, Peru
  • Footnotes
    Commercial Relationships Luis Izquierdo, None; Maria Henriquez, None; ana rodriguez, None; giovanna henriquez, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3008. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Luis Izquierdo, Maria A Henriquez, ana rodriguez, giovanna henriquez; Accelerate Epi-on versus standard epi-off corneal crosslinking for progressive keratoconus in pediatric patients.. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3008.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evaluate and compare the effectiveness and safety of accelerate transepithelial (epi-on) corneal collagen crosslinking (CXL) compared to standard CXL (epi-off) in children with progressive keratoconus.

Methods: Prospective, comparative, study included 56 patients younger than 18 years old with progressive keratoconus between November 2013 to December 2014 . Accelerate transepithelial CXL (epi-on) was performed in 34 eyes using 30 minutes of impregnation, 5 minutes of irradiation (18mW), using TE-riboflavin and CCL-VARIO (Peschke Ltd, Germany). Standard CXL (epi-on) was performed in 22 eyes using 30 minutes of impregnation, 30 minutes of irradiation (3 mW/cm2), isotonic riboflavin 0.1%/dextran 20% solution and CCL-VARIO (Peschke Ltd, Germany). Scheimpflug imaging parameters where evaluated at pre and postoperatively at 1, 6 and 12 months.

Results: Mean maximum keratometry change from 49.52 um to 48.90 um (p = 0.009) in the standar epi-off group and from 49.54 um to 49.33 um in the epi-off group (p = 0.034) at 6 months. Mean uncorrected visual acuity (UCVA) change from 0.62 um to 0.60 (p = 0.06) in the epi-on group and from 0.60 to 0.45 LogMAR in the epi-off group (p = 0.03) at 6 months. There was not statistical significant in terms of visual acuity, keratometry and posterior elevation values between groups (P>.05) at 6 months postoperatively. There were not complications reported in this group of patients. Results at 12 months will be presented later.

Conclusions: Both accelerate crosslinking epi-on and standard epi-off procedures are safe and efficacy to stop the progression of the keratoconus at 6 months postoperatively. Longer follow up is necessary to confirm these results.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×